Determination of the Antidiabetic Effectiveness of Green Round Eggplant (Solanum xanthocarpum) Compounds in a Nanoliposome Preparation on Insulin Levels of Alloxan-Induced Diabetic Rats
DOI:
https://doi.org/10.35451/jfm.v9i1.4035Keywords:
Alloxan, Antidiabetic, Insulin, Nanoliposome, Solanum xanthocarpumAbstract
The low oral bioavailability of plant secondary metabolites remains a major obstacle in developing antidiabetic phytopharmaceuticals. This study aimed to determine the antidiabetic effectiveness of green round eggplant (Solanum xanthocarpum Schrad. & Wendl.) fruit compounds, formulated as an ethyl acetate extract (EEATBH) and as nanoliposomes of the ethyl acetate extract (NEEATBH), based on serum insulin levels in alloxan-induced diabetic rats. The dried crude drug was characterised according to the Indonesian Materia Medica, macerated with ethyl acetate, and formulated into three nanoliposomes (F1–F3) with varying Span 60 content (70, 80, and 90 mg) using thin-film hydration followed by 30-minute sonication. Thirty male Wistar rats were divided into six groups (n = 5) and rendered diabetic with alloxan 150 mg/kg BW intraperitoneally, then treated orally with 1% Na-CMC (negative control), glibenclamide 0.09 mg/kg BW (positive control), NEEATBH at 25, 50, and 100 mg/kg BW, and EEATBH at 100 mg/kg BW. Serum insulin was quantified by ELISA at 450 nm and analysed by one-way ANOVA followed by Tukey’s test (α = 0.05). The extract contained saponins, tannins, flavonoids, glycosides, and steroids/triterpenoids, with a yield of 1.71%. Formula F3 produced the smallest particle size (44.93 nm) at pH 6.0 ± 0.12 and was selected for the in vivo assay. All treatment groups significantly raised insulin levels relative to the negative control (107.443 ± 0.836 pg/mL; p < 0.001). The highest insulin level was achieved by NEEATBH 100 mg/kg BW (615.223 ± 4.599 pg/mL), exceeding both glibenclamide (507.000 ± 1.000 pg/mL) and the equivalent dose of EEATBH (485.000 ± 1.837 pg/mL), corresponding to a relative effectiveness of 127.09% against glibenclamide. The insulin response was dose-dependent (r2 = 0.970). Liposomal nanoencapsulation increased the net insulinotropic effect of the extract by 34.5% at an identical dose. Nanoliposomes of the S. xanthocarpum ethyl acetate extract are therefore more effective than the conventional extract in elevating insulin levels in diabetic rats.
Downloads
References
1. Magliano DJ, Boyko EJ; Diabetes Atlas 11th Edition Scientific Committee. IDF Diabetes Atlas. 11th ed. Brussels: International Diabetes Federation; 2025.
2. Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S, et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14(2):149–56. doi:10.1016/S2213-8587(25)00299-2
3. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51(2):216–26. doi:10.1007/s00125-007-0886-7
4. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50(6):537–46.
5. Saxena HO, Deshmukh A, Ganesh, Kakkar A, Singh N. Phytochemical screening and assessment of secondary metabolites in different plant parts of Solanum xanthocarpum: a Dashmool species. Indian J Trop Biodiv. 2014;22(2):164–9.
6. Khanam S, Sultana R. Isolation of β-sitosterol and stigmasterol as active immunomodulatory constituents from fruits of Solanum xanthocarpum (Solanaceae). Int J Pharm Sci Res. 2012;3(4):1057–60.
7. Singh OM, Singh TP. Phytochemistry of Solanum xanthocarpum: an amazing traditional healer. J Sci Ind Res. 2012;69:732–40.
8. Jayakumar K, Murugan K. Solanum alkaloids and their pharmaceutical roles: a review. J Anal Pharm Res. 2016;3(6):1–12. doi:10.15406/japlr.2016.03.00075
9. Kar DM, Maharana L, Pattnaik S, Dash GK. Studies on hypoglycaemic activity of Solanum xanthocarpum Schrad. & Wendl. fruit extract in rats. J Ethnopharmacol. 2006;108(2):251–6. doi:10.1016/j.jep.2006.05.016
10. Gupta AK, Ganguly P, Majumder UK, Ghosal S. Antidiabetic and antihyperlipidaemic effects of Solanum xanthocarpum total extract in alloxan induced diabetic rats. Pharmacologyonline. 2009;1:487–97.
11. Poongothai K, Ponmurugan P, Ahmed KS, Kumar BS, Sheriff SA. Antihyperglycemic and antioxidant effects of Solanum xanthocarpum leaves (field grown and in vitro raised) extracts on alloxan induced diabetic rats. Asian Pac J Trop Med. 2011;4(10):778–85. doi:10.1016/S1995-7645(11)60193-4
12. Kumar S, Pandey AK. Medicinal attributes of Solanum xanthocarpum fruit consumed by several tribal communities as food: an in vitro antioxidant, anticancer and anti-HIV perspective. BMC Complement Altern Med. 2014;14:112. doi:10.1186/1472-6882-14-112
13. Sridevi M, Senthil S, Pugalendi KV. Antihyperglycemic effect of Solanum surattense leaf extract in streptozotocin-induced diabetic rats. J Pharmacol Toxicol. 2011;2(7):621–9.
14. Ivorra MD, D’Ocon MP, Paya M, Villar A. Antihyperglycemic and insulin-releasing effects of β-sitosterol 3-β-D-glucoside and its aglycone β-sitosterol. Arch Int Pharmacodyn Ther. 1988;296:224–31.
15. Gupta R, Sharma AK, Dobhal MP, Sharma MC, Gupta RS. Antidiabetic and antioxidant potential of β-sitosterol in streptozotocin-induced experimental hyperglycemia. J Diabetes. 2011;3(1):29–37. doi:10.1111/j.1753-0407.2010.00107.x
16. Kanchan DM, Somani GS, Peshattiwar VV, Kaikini AA, Sathaye S. Renoprotective effect of diosgenin in streptozotocin induced diabetic rats. Pharmacol Rep. 2016;68(2):370–7. doi:10.1016/j.pharep.2015.10.011
17. Eid HM, Haddad PS. The antidiabetic potential of quercetin: underlying mechanisms. Curr Med Chem. 2017;24(4):355–64. doi:10.2174/0929867323666160909153707
18. Vinayagam R, Xu B. Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab (Lond). 2015;12:60. doi:10.1186/s12986-015-0057-7
19. Ghorbani A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomed Pharmacother. 2017;96:305–12. doi:10.1016/j.biopha.2017.10.001
20. Sales PM, Souza PM, Simeoni LA, Silveira D. α-Amylase inhibitors: a review of raw material and isolated compounds from plant source. J Pharm Pharm Sci. 2012;15(1):141–83. doi:10.18433/J35S3K
21. Kakran M, Shegokar R, Sahoo NG, Al Shaal L, Li L, Müller RH. Fabrication of quercetin nanocrystals: comparison of different methods. Eur J Pharm Biopharm. 2012;80(1):113–21. doi:10.1016/j.ejpb.2011.08.006
22. Zhang H. Thin-film hydration followed by extrusion method for liposome preparation. Methods Mol Biol. 2017;1522:17–22. doi:10.1007/978-1-4939-6591-5_2
23. Mozafari MR. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett. 2005;10(4):711–9.
24. van Hoogevest P, Wendel A. The use of natural and synthetic phospholipids as pharmaceutical excipients. Eur J Lipid Sci Technol. 2014;116(9):1088–107. doi:10.1002/ejlt.201400219
25. Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975–99. doi:10.2147/IJN.S68861
26. Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27(4):1372. doi:10.3390/molecules27041372
27. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57. doi:10.3390/pharmaceutics10020057
28. Khorasani S, Danaei M, Mozafari MR. Nanoliposome technology for the food and nutraceutical industries. Trends Food Sci Technol. 2018;79:106–15. doi:10.1016/j.tifs.2018.07.009
29. Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems a review (part 1). Trop J Pharm Res. 2013;12(2):255–64. doi:10.4314/tjpr.v12i2.19
30. Munot N, Kandekar U, Giram PS, Khot K, Patil A, Cavalu S. A comparative study of quercetin-loaded nanocochleates and liposomes: formulation, characterization, assessment of degradation and in vitro anticancer potential. Pharmaceutics. 2022;14(8):1601. doi:10.3390/pharmaceutics14081601
31. Simarmata Y, Arianto A, Widyawati T, Nasution P. Formulation and evaluation of physical stability and antidiabetic activity from nanoliposomes containing an ethyl acetate extract of Solanum xanthocarpum Schrader & Wendland fruit in rats. J Herbmed Pharmacol. 2024;13(4):596–605. doi:10.34172/jhp.2024.51491
32. Departemen Kesehatan Republik Indonesia. Materia Medika Indonesia. Jilid VI. Jakarta: Direktorat Jenderal Pengawasan Obat dan Makanan; 1995.
33. Kementerian Kesehatan Republik Indonesia. Farmakope Herbal Indonesia. Edisi II. Jakarta: Kementerian Kesehatan RI; 2017.
34. Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Yettrie Simarmata, Salmah Handayani Lubis, Linda Margata
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright in each article is the property of the Author.
